| dc.contributor |
School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Cape Town, South Africa. andrew.boulle@uct.ac.za |
|
| dc.creator |
Boulle, Andrew |
|
| dc.creator |
Van Cutsem, Gilles |
|
| dc.creator |
Hilderbrand, Katherine |
|
| dc.creator |
Cragg, Carol |
|
| dc.creator |
Abrahams, Musaed |
|
| dc.creator |
Mathee, Shaheed |
|
| dc.creator |
Ford, Nathan |
|
| dc.creator |
Knight, Louise |
|
| dc.creator |
Osler, Meg |
|
| dc.creator |
Myers, Jonny |
|
| dc.creator |
Goemaere, Eric |
|
| dc.creator |
Coetzee, David |
|
| dc.creator |
Maartens, Gary |
|
| dc.date |
2010-02-20 |
|
| dc.date.accessioned |
2017-01-31T07:16:32Z |
|
| dc.date.available |
2017-01-31T07:16:32Z |
|
| dc.identifier |
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. 2010, 24 (4):563-72 AIDS |
|
| dc.identifier |
1473-5571 |
|
| dc.identifier |
20057311 |
|
| dc.identifier |
10.1097/QAD.0b013e328333bfb7 |
|
| dc.identifier |
http://hdl.handle.net/10144/95573 |
|
| dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/95573 |
|
| dc.identifier |
AIDS (London, England) |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/95573 |
|
| dc.description |
OBJECTIVES: We report on outcomes after 7 years of a community-based antiretroviral therapy (ART) programme in Khayelitsha, South Africa, with death registry linkages to correct for mortality under-ascertainment. DESIGN: This is an observational cohort study. METHODS: Since inception, patient-level clinical data have been prospectively captured on-site into an electronic patient information system. Patients with available civil identification numbers who were lost to follow-up were matched with the national death registry to ascertain their vital status. Corrected mortality estimates weighted these patients to represent all patients lost to follow-up. CD4 cell count outcomes were reported conditioned on continuous virological suppression. RESULTS: Seven thousand, three hundred and twenty-three treatment-naive adults (68% women) started ART between 2001 and 2007, with annual enrolment increasing from 80 in 2001 to 2087 in 2006. Of 9.8% of patients lost to follow-up for at least 6 months, 32.8% had died. Corrected mortality was 20.9% at 5 years (95% confidence interval 17.9-24.3). Mortality fell over time as patients accessed care earlier (median CD4 cell count at enrolment increased from 43 cells/microl in 2001 to 131 cells/microl in 2006). Patients who remained virologically suppressed continued to gain CD4 cells at 5 years (median 22 cells/microl per 6 months). By 5 years, 14.0% of patients had failed virologically and 12.2% had been switched to second-line therapy. CONCLUSION: At a time of considerable debate about future global funding of ART programmes in resource-poor settings, this study has demonstrated substantial and durable clinical benefits for those able to access ART throughout this period, in spite of increasing loss to follow-up. |
|
| dc.language |
en |
|
| dc.rights |
Published by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluwer |
|
| dc.title |
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. |
|